Literature DB >> 19935059

Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases.

Lizhi Zhang1, Thomas C Smyrk, William F Young, Constantine A Stratakis, J Aidan Carney.   

Abstract

Carney triad, as originally described in 1977, was the association of 3 tumors: gastric epithelioid leiomyosarcoma [later renamed gastrointestinal stromal tumor (GIST)], extra-adrenal paraganglioma, and pulmonary chondroma. The disorder affected mostly young women and was not familial. We studied the clinical and pathologic features of the gastric neoplasm in 104 patients with the syndrome. Most (88%) were young women (mean age, 22 y), and the usual presentation was gastric bleeding. The tumors, commonly antral-based (61%), were multifocal, and ranged from 0.2 to 18.0 cm in dimension. Most (86%) featured round and polygonal (epithelioid) cells. Metastasis occurred in 49 patients (47%): to gastric lymph nodes (29%), liver (25%), and peritoneum (13%). Immunopositivity was detected in the tumors tested as follows: KIT, 100%; CD34, 75%; PKCtheta, 21%; PDGFRA, 90%; and smooth muscle actin, 6%. Fourteen patients (13%) died of metastatic GIST at a mean age of 45 years (range, 30 to 69 y). Estimated 10 and 40-year survivals were 100% and 73%, respectively. Median survival time was 26.5 years (range, 16 to 60 y). There was no correlation between the National Institutes of Health tumor risk classification and the tumor behavior. Compared with sporadic gastric GISTs, the gastric stromal tumor in Carney triad showed distinctive features: female predilection, young patient age, epithelioid cell predominance, multifocality, frequent lymph node metastasis, serial tumor occurrence, and unpredictable behavior. Thus, the Carney triad gastric stromal tumor is different clinically, pathologically, and behaviorally from sporadic gastric GIST.

Entities:  

Mesh:

Year:  2010        PMID: 19935059      PMCID: PMC3652406          DOI: 10.1097/PAS.0b013e3181c20f4f

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  67 in total

1.  [Intramural myoid tumors of the stomach. Microscopic considerations on 6 cases].

Authors:  J F MARTIN; P BAZIN; J FEROLDI; F CABANNE
Journal:  Ann Anat Pathol (Paris)       Date:  1960 Oct-Dec

2.  Successful liver transplantation in two cases of metastatic gastrointestinal stromal tumors.

Authors:  Silke Cameron; Giuliano Ramadori; Laszlo Füzesi; Burkhart Sattler; Bastian Gunawan; Dieter Müller; Burkhardt Ringe; Thomas Lorf
Journal:  Transplantation       Date:  2005-07-27       Impact factor: 4.939

3.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

4.  NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics.

Authors:  Johanna Andersson; Harri Sihto; Jeanne M Meis-Kindblom; Heikki Joensuu; Nina Nupponen; Lars-Gunnar Kindblom
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

Review 5.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

6.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

Review 7.  Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients < or = 40 years: an overview based on our case material and the literature.

Authors:  Abbas Agaimy; Peter H Wünsch
Journal:  Langenbecks Arch Surg       Date:  2008-12-23       Impact factor: 3.445

8.  Multicentric sporadic gastrointestinal stromal tumors (GISTs) of the stomach with distinct clonal origin: differential diagnosis to familial and syndromal GIST variants and peritoneal metastasis.

Authors:  Florian Haller; Hans-Jürgen Schulten; Thomas Armbrust; Claus Langer; Bastian Gunawan; László Füzesi
Journal:  Am J Surg Pathol       Date:  2007-06       Impact factor: 6.394

Review 9.  The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.

Authors:  C A Stratakis; J A Carney
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

10.  A tense case--Carney's triad.

Authors:  John C Bladen; Mariya Moosajee; J H Duncan Bassett
Journal:  J R Soc Med       Date:  2004-11       Impact factor: 18.000

View more
  65 in total

1.  Carney Stratakis syndrome in a patient with SDHD mutation.

Authors:  Carmen Tenorio Jiménez; Louise Izatt; Fuju Chang; Mufaddal T Moonim; Paul V Carroll; Barbara M McGowan
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

2.  Gastric Gist with Syncronous Ampullary Gangliocytic Paraganglyoma: A Novel Presentation of an Incomplete Carney's Triad.

Authors:  Marco A Juarez-Parra; Eduardo A Guzman-Huerta; Gerardo Ochoa-Rodriguez; Jesús Limon-Rodriguez; Zaire Zamudio-Vazquez; Luis Gregorio Osoria-Alba; Maria Jose González-Salazar; Jessica S Cordova-Chavez
Journal:  J Gastrointest Cancer       Date:  2015-09

3.  Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs).

Authors:  Antônio Talvane Torres de Oliveira; Céline Pinheiro; Adhemar Longatto-Filho; Maria Jose Brito; Olga Martinho; Delcio Matos; André Lopes Carvalho; Vinícius Lima Vazquez; Thiago Buosi Silva; Cristovam Scapulatempo; Sarhan Sydney Saad; Rui Manuel Reis; Fátima Baltazar
Journal:  J Bioenerg Biomembr       Date:  2012-01-27       Impact factor: 2.945

Review 4.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

5.  Predictors of lymph node metastasis in patients with gastrointestinal stromal tumors (GISTs).

Authors:  Apostolos Gaitanidis; Mustapha El Lakis; Michail Alevizakos; Alexandra Tsaroucha; Michail Pitiakoudis
Journal:  Langenbecks Arch Surg       Date:  2018-05-31       Impact factor: 3.445

Review 6.  The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations.

Authors:  Sosipatros A Boikos; Constantine A Stratakis
Journal:  Endocrine       Date:  2014-07-16       Impact factor: 3.633

Review 7.  Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome.

Authors:  Nikolaos Settas; Fabio R Faucz; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2017-07-21       Impact factor: 4.102

Review 8.  [Translational research and diagnosis in GIST].

Authors:  E Wardelmann
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 9.  Succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Authors:  Ya-Mei Wang; Meng-Li Gu; Feng Ji
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 10.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.